Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled, Multicentre, Parallel Group Study of the Safety, Tolerability and Efficacy of V3381 for up to 13 Weeks in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

NCT00794430 is registered in ClinicalTrials.gov with Vernalis (R&D) Ltd as lead sponsor.

NCT NCT00794430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00794430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled, Multicentre, Parallel Group Study of the Safety, Tolerability and Efficacy of V3381 for up to 13 Weeks in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
Lead sponsor
Vernalis (R&D) Ltd
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
December 31, 2009
Enrollment
161 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathic pain